Primo Chemicals Q2 FY27 Share Price & Earnings Call Analysis

₹21.91-3.18% today
Market cap
₹531 Cr
P/E
34.01
ROE
3.78%
PEG
-0.65
Price to sales
0.95
Debt to equity
0.32
52W high / low
₹28.1 / ₹16.9
Sales growth (5Y)
20.17%
EBITDA margin
12.27%
Net profit margin
2.70%
Promoter holding
32.40%
Sales (last year)
₹560 Cr

Incorporated in 1975, Primo Chemicals Ltd (formerly Punjab Alkalies & Chemicals Ltd) is in the business of manufacturing & selling of chemicals[1]

Potential multibaggers · Q2 FY27

Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance

  1. Strong growth
    2
  2. Strong growth
    1
  3. Strong growth
    3

Portfolio builder

Build your portfolio
from the top-ranked stocks

  1. 1. Pick 3–15 stocks
  2. 2. Choose large, mid or small cap and your sectors
  3. 3. Get a portfolio built from the rankings
Build my portfolio

Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.

Peers

Chemicals & Petrochemicals companies ranked on guidance

#CompanyRevenue guidedMargin guidedMarket capP/E
140%+Up 0–2%₹234 Cr3.0
240%+Flat₹3,888 Cr48.5
340%+Flat₹3,514 Cr4.3
440%+Flat₹180 Cr11.9
540%+Flat₹138 Cr15.1
620–40%Up 2%+₹1.70L Cr85.4

Primo Chemicals announcements

All announcements →

Financials of Primo Chemicals

Quarterly Results, Profit & Loss, Balance Sheet, Cash Flows, and Ratios are shown below as separate sections.

Shareholder Pattern

Primo Chemicals

Shareholding breakup across reporting periods.

Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Promoters +31.36%31.35%31.35%31.35%31.35%31.35%31.35%31.35%32.40%32.40%32.40%32.40%
FIIs +1.78%0.73%0.23%0.11%0.12%0.11%0.11%0.08%0.08%0.09%0.32%0.28%
DIIs +1.92%1.92%1.92%1.92%1.92%1.92%1.92%1.92%1.92%1.92%1.92%1.92%
Public +64.96%65.99%66.50%66.61%66.61%66.61%66.61%66.65%65.61%65.61%65.36%65.41%
No. of Shareholders42,40345,39845,32452,60951,48150,40450,06549,93049,27247,99748,30848,764

Financials of Primo Chemicals

Quarterly Results

Quarter-by-quarter operating performance

Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026Sep 2026
Sales +93.2091.43102.48121.93134.36143.85155.42141.94134.74140.14144.86140.28134.84
Expenses +97.5588.64101.05106.82123.76125.20131.44121.55119.44126.56125.84119.48128.54
Operating Profit-4.352.791.4315.1110.6018.6523.9820.3915.3013.5819.0220.806.30
OPM %-4.67%3.05%1.40%12.39%7.89%12.96%15.43%14.37%11.36%9.69%13.13%14.83%4.67%
Other Income +4.843.705.425.875.864.744.415.274.464.225.665.245.04
Interest4.385.015.785.605.675.955.785.464.824.343.883.693.96
Depreciation9.0110.2811.5712.3413.2213.0212.5213.1113.2313.2512.9813.4913.47
Profit before tax-12.90-8.80-10.503.04-2.434.4210.097.091.710.217.828.86-6.09
Tax %5.19%74.32%-164.57%485.20%-645.68%56.56%111.10%56.84%-61.40%261.90%34.91%58.92%-94.25%
Net Profit +-12.94-15.197.09-11.2512.932.29-0.414.084.161.056.074.68-0.41
EPS in Rs-0.53-0.630.29-0.460.530.09-0.020.170.170.040.250.19-0.02

Financials of Primo Chemicals

Profit & Loss

Annual income statement trend

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales +223449701392549558560
Expenses +235362508385481489500
Operating Profit-12871927686860
OPM %-6%19%27%1.8%12%12%11%
Other Income +55152619212020
Interest59818231816
Depreciation17172440515353
Profit before tax2076186-31151711
Tax %59%25%28%-18%85%37%
Net Profit +859137-2541511
EPS in Rs0.532.445.67-1.050.150.630.46
Dividend Payout %0%0%0%0%0%0%

Financials of Primo Chemicals

Balance Sheet

Capital structure and asset base

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026Sep 2026
Equity Capital31484848484848
Reserves66228364339342358353
Borrowings +161145178169131220
Other Liabilities +148141174149181155243
Total Liabilities246478731714741692864
Fixed Assets +156155278468497469557
CWIP3517721349101212
Investments033595961650
Other Assets +55114181138173145295
Total Assets246478731714741692864

Financials of Primo Chemicals

Cash Flows

Operating, investing and financing cash movement

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from Operating Activity +5370150146465
Cash from Investing Activity +-24-191-233-56-43-18
Cash from Financing Activity +-341378121-22-46
Net Cash Flow-516-3-21-01
Free Cash Flow29-86-33-512639
CFO/EBITDA Share of operating profit converting into cash: CFO (before tax) / Operating Profit-421%97%95%397%94%97%

Financials of Primo Chemicals

Ratios

Working capital efficiency and return ratios

Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Debtor Days272627332821
Inventory Days528447106104114
Days Payable231216112147195115
Cash Conversion Cycle-152-106-38-8-6320
Working Capital Days-160-47-31-89-67-59
ROCE %39%43%-2%7%6%
21out of 100

Momentum score · price trend

21 out of 100 — Cooling

Over the past year its share price has done worse than most of the stocks we track.

PeriodShare price changeBetter than … of 1,910 stocks
Last 12 months−6.4%53%
Last 6 months−14.3%30%
Last 3 months−9.8%45%

The price is 77.5% below its all-time high of ₹97.4 (13 Apr 2022). Stocks more than 20% below their peak have their score halved, so 42 became 21.

How we calculate it

“Better than 30%” means that over that period the share price did better than 30 out of every 100 stocks we track (1,910 Indian companies worth ₹500 Cr or more, with at least a year of prices).

The score weighs the longer periods more: 40% × 12-month + 40% × 6-month + 20% × 3-month. For Primo Chemicals: 0.4 × 53 + 0.4 × 30 + 0.2 × 45 = 42, halved to 21 because the price is more than 20% below its all-time high.

Strengthening is 70 and above, Steady 40 to 70, Cooling below 40. Scores are recalculated every night after the market closes.

Full methodology →

This describes only how the share price has moved up to 2 Nov 2026, compared with other stocks. It says nothing about the business, and it is not a prediction, a price target or a recommendation to buy or sell.

What Primo Chemicals's management said in earlier quarters

Others in Chemicals & Petrochemicals this season

  • Camlin Fine (Q2 FY27)

    Q2 FY27 revenue: Rs 4,915 mn, up 9.15% YoY from Rs 4,503 mn in Q2 FY26 (Page 6, 9) . Key investor presentation takeaways from Camlin Fine Sciences Ltd's Q2 FY27

  • Gujarat Fluoroch (Q2 FY27)

    Consolidated Q2FY27 revenue: ₹1,760 crore, up 45% YoY (Q2FY26: ₹1,210 crore). Key investor presentation takeaways from Gujarat Fluorochemicals Ltd's Q2 FY27 inv

  • Bodal Chemicals (Q2 FY27)

    8,840 mn, up 77% YoY (from Rs. Key investor presentation takeaways from Bodal Chemicals Ltd's Q2 FY27 investor presentation — and how it ranks against sector pe

  • Solar Industries (Q2 FY27)

    3,519 crore, up 69% YoY from Rs. Key investor presentation takeaways from Solar Industries India Ltd's Q2 FY27 investor presentation — and how it ranks against